Literature DB >> 12000388

Systemic lupus erythematosus induced by Epstein-Barr virus infection.

R Verdolini1, L Bugatti, M Giangiacomi, M Nicolini, G Filosa, R Cerio.   

Abstract

We report a 22-year-old woman who developed systemic lupus erythematosus (SLE) immediately after an Epstein-Barr virus (EBV)-induced mononucleosis infection. The link between these two conditions has long been suspected. The close temporal relationship, the course of the pathological events and the development of immunological changes in this case provide further evidence supporting the hypothesis that EBV infection could work as a trigger in some cases of SLE, particularly if the patient is genetically susceptible.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12000388     DOI： 10.1046/j.1365-2133.2002.04627.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  12 in total

1.  Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells.

Authors:  Timothy E Quan; Robert M Roman; Benjamin J Rudenga; V Michael Holers; Joseph E Craft
Journal:  Arthritis Rheum       Date:  2010-06

2.  Induction of pathogenic anti-dsDNA antibodies is controlled on the level of B cells in a non-lupus prone mouse strain.

Authors:  Dirk Langnickel; Philipp Enghard; Claudia Klein; Reinmar Undeutsch; Berthold Hocher; R Manz; G R Burmester; Gabriela Riemekasten
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

3.  A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.

Authors:  B Löfström; C Backlin; C Sundström; A Ekbom; I E Lundberg
Journal:  Ann Rheum Dis       Date:  2007-05-21       Impact factor: 19.103

4.  Aberrant Epstein-Barr viral infection in systemic lupus erythematosus.

Authors:  Brian D Poole; Amanda K Templeton; Joel M Guthridge; Eric J Brown; John B Harley; Judith A James
Journal:  Autoimmun Rev       Date:  2009-01-22       Impact factor: 9.754

Review 5.  New therapeutic strategies in systemic lupus erythematosus management.

Authors:  Mariele Gatto; Margherita Zen; Luca Iaccarino; Andrea Doria
Journal:  Nat Rev Rheumatol       Date:  2019-01       Impact factor: 20.543

6.  Multiple granulomatous lung lesions in a patient with Epstein-Barr-virus-induced mononucleosis and new-onset systemic lupus erythematosus: a case report.

Authors:  Aki Sakurai; Shinichi Shimizu; Shinichiro Morioka; Tetsuo Fujita; Ryogo Ema; Yoshihiro Miki; Kazuhiro Tomita; Toru Nakamura; Futoru Toyoda; Yoshiro Otsuki; Hiroshi Kobayashi; Hidenori Nakamura
Journal:  J Med Case Rep       Date:  2012-07-09

7.  Systemic lupus erythematosus due to Epstein-Barr virus or Epstein-Barr virus infection provocating acute exacerbation of systemic lupus erythematosus?

Authors:  Ozgur Kasapcopur; Yakup Ergul; Seyhan Kutlug; Cengiz Candan; Yildiz Camcioglu; Nil Arisoy
Journal:  Rheumatol Int       Date:  2005-10-01       Impact factor: 3.580

8.  Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production.

Authors:  Shui-Lian Yu; Chun-Kwok Wong; Purple Tsz-Yan Wong; Da-Peng Chen; Cheuk-Chun Szeto; Edmund K Li; Lai-Shan Tam
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

Review 9.  Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.

Authors:  Shui-Lian Yu; Woon-Pang Kuan; Chun-Kwok Wong; Edmund K Li; Lai-Shan Tam
Journal:  Clin Dev Immunol       Date:  2012-01-23

10.  Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1.

Authors:  Robert M Valente; Erica Ehlers; Dongsheng Xu; Humera Ahmad; Andrew Steadman; Laura Blasnitz; You Zhou; Lisa Kastanek; Bin Meng; Luwen Zhang
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.